Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis

被引:8
|
作者
Ilzecka, J. [1 ]
机构
[1] Med Univ Lublin, Dept Neurol, PL-20954 Lublin, Poland
关键词
amyotrophic lateral sclerosis; apoptosis; cerebrospinal fluid; cytochrome c; oxidative stress; serum;
D O I
10.1080/00365510601016105
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective. There is evidence showing impaired mitochondrial energy production and increased oxidative damage to mitochondria in amyotrophic lateral sclerosis (ALS). It is known that a lack of cytochrome c (CyC) in the mitochondrial intermembrane space can increase free radical release from mitochondria through interruption of the electron transport. CyC also plays a role in the apoptotic cell death which is suspected in ALS. The aim of the study was to measure cerebrospinal fluid (CSF) and serum CyC levels in patients with ALS. Material and methods. Forty ALS patients were diagnosed according to the El Escorial criteria of ALS. The clinical state of the patients was measured using the Amyotrophic Lateral Sclerosis Functional Rating Scale [ALSFRS]. Results. It was shown that overall CyC levels were significantly decreased by 46 % in the CSF of patients with ALS compared with controls (p < 0.05), and not affected in serum of patients with ALS (p > 0.05). There was no significant difference in CyC levels in relation to the clinical parameters of the disease (p > 0.05). Conclusions. The study indicates that CyC may play a role in the pathogenesis of ALS. A possible mechanism is that increased neurodegeneration in ALS caused by free radical production decreases the concentrations of CyC.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 50 条
  • [1] Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis
    Watanabe, Shohei
    Kimura, Takashi
    Suenaga, Koichi
    Wada, Sayoko
    Tsuda, Kenkichi
    Kasama, Shuhei
    Takaoka, Toshio
    Kajiyama, Koji
    Takeda, Masanaka
    Yoshikawa, Hiroo
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 (1-2) : 146 - 148
  • [2] Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis
    J. Iłżecka
    [J]. Journal of Neural Transmission, 2004, 111 : 167 - 172
  • [3] Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis
    Ilzecka, J
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (02) : 167 - 172
  • [4] Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis
    Ren, Yuting
    Zhu, Wenjia
    Cui, Fang
    Yang, Fei
    Chen, Zhaohui
    Ling, Li
    Huang, Xusheng
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5419 - 5426
  • [5] Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis
    Verde, Federico
    Steinacker, Petra
    Oeckl, Patrick
    Weishaupt, Jochen H.
    Rosenbohm, Angela
    Silani, Vincenzo
    Ludolph, Albert C.
    Otto, Markus
    [J]. NEUROBIOLOGY OF AGING, 2018, 67 : 21 - 22
  • [6] Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients
    Zheng, Y.
    Gao, L.
    Wang, D.
    Zang, D.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (02): : 145 - 150
  • [7] Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis
    T. Matsuishi
    S. Nagamitsu
    H. Shoji
    M. Itoh
    S. Takashima
    T. Iwaki
    N. Shida
    Y. Yamashita
    T. Sakai
    H. Kato
    [J]. Journal of Neural Transmission, 1999, 106 : 943 - 948
  • [8] RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis
    Rentzos, Michael
    Nikolaou, Chryssoula
    Rombos, Antonis
    Boufidou, Fotini
    Zoga, Margarita
    Dimitrakopoulos, Antonis
    Tsoutsou, Anthousa
    Vassilopoulos, Demetrios
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2007, 8 (05): : 283 - 287
  • [9] Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis
    Kawajiri, M.
    Mogi, M.
    Higaki, N.
    Tateishi, T.
    Ohyagi, Y.
    Horiuchi, M.
    Miki, T.
    Kira, J. -I.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2009, 119 (05): : 341 - 344
  • [10] Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis
    Matsuishi, T
    Nagamitsu, S
    Shoji, H
    Itoh, M
    Takashima, S
    Iwaki, T
    Shida, N
    Yamashita, Y
    Sakai, T
    Kato, H
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (9-10) : 943 - 948